NMC.L Regulatory News (NMC)

NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, HONG KONG, JAPAN, KUWAIT, QATAR, SINGAPORE, SAUDI ARABIA, SWITZERLAND OR THE UNITED ARAB EMIRATES.

2nd April 2012

NMC Health plc

Announcement of Offer Price of 210 pence per Ordinary Share

NMC Health plc (the "Company"), a leading integrated UAE healthcare provider, today announces the successful pricing of its initial public offering of 55.7 million Ordinary Shares (the "Offer") at 210 pence per Ordinary Share (the "Offer Price") and admission to the premium listing segment of the Official List and to trading on the London Stock Exchange.

·; The Offer comprises 55.7 million Ordinary Shares of 10 pence each at an Offer Price of 210 pence per share (assuming no exercise of the Over-allotment Option), all of which will be New Shares issued by NMC Health plc.

·; Based on the Offer Price, the Offer will raise gross proceeds of approximately £117.0 million, all of which will be primary proceeds received by the Company.

·; An Over-Allotment Option consisting entirely of Existing Shares has been granted in respect of 15% of the Offer by the Existing Shareholders.

·; Based on the Offer Price and the number of shares in issue of approximately 185.7 million, the market capitalisation of the Company at listing will be approximately £390 million.

·; Conditional dealings are expected to commence at 8.00 a.m. on 2 April 2012 on the London Stock Exchange under the ticker symbol NMC. It is expected that admission of NMC Health plc's Ordinary Shares to the Official List of the London Stock Exchange will become effective and unconditional dealings will commence at 8.00 a.m. on 5 April 2012.

·; NMC Health plc is the first Abu Dhabi company to list on the premium listing segment of the London Stock Exchange.

·; Deutsche Bank is acting as Sole Global Co-ordinator, Sole Sponsor and Sole Bookrunner to the listing. Numis Securities Limited and SHUAA Capital are acting as Joint Lead Manager and One Financial Markets and Deloitte Corporate Finance are acting as Financial Advisers.

His Excellency, Mr. Saeed Bin Butti, Non-Executive Director, said:

"This is an exciting moment for NMC and testament to the quality of its business and track record. The company is operating in a dynamic region with strong growth potential and very favourable demographics. This offering will enable NMC to capture these opportunities, and cement its position as a leader in the UAE healthcare market."

Mark Tompkins, Non-Executive Chairman, said:

"I look forward to working with the Board and management team to accelerate NMC's impressive growth trajectory as a public company and deliver strong returns to our international shareholder base."

Dr. B.R. Shetty, founder, Managing Director and Chief Executive Officer of NMC, said:

"NMC is a quality company with a 37 year history of delivering the highest standards of healthcare as well as profitable growth. We are proud to be the first Abu Dhabi company to list on the London market and are very pleased with the strong participation in the Offer from a broad range of investors in the United Kingdom, Europe, the United States and the Middle East. The funds we have raised will enable us to implement our exciting growth plans which include developing new and existing facilities and funding future growth opportunities for the benefit of our patients and shareholders alike. We look forward to the next phase of NMC's development as a London-listed company."

Mr. Khalifa Bin Butti, Executive Vice Chairman of NMC, said:

"We are delighted to see that such a broad range of shareholders have taken the opportunity to invest in NMC, which is a clear leader in its field. NMC has an exceptional track record and growth story with a management team in place that can continue to drive the business forward."

- ENDS -

Enquiries:

Brunswick LondonJustine McIlroy +44 20 7404 5959Azadeh Varzi

Brunswick GulfSteve Martin +971 5 6696 9232Wajih Halawa +971 5 0100 9207

Deutsche BankFrank Kennedy +44 20 7545 8000Christopher Laing Martin Pengelley

Numis SecuritiesMichael Meade +44 20 7260 1000Nick WestlakeJames Black

SHUAA CapitalKarim Schoeib +971 4 319 9789Hani Buttikhi +971 5 045 8 9128

This document is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States, Australia, Canada, Hong Kong, Japan, Kuwait, Qatar, Singapore, Saudi Arabia, Switzerland or the United Arab Emirates. The securities to which these materials relate (the "Securities") in NMC Health plc have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to an exemption from, or a transaction not subject to, registration under the Securities Act. There will be no public offer of the Securities in the United States.

This document is only being distributed to and is only directed at: (i) persons who are outside the United Kingdom; or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). The Securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.

The Securitieshave not been, and are not being, publicly offered, sold, promoted or advertised in the United Arab Emirates and/or the Dubai International Financial Centre (the "DIFC") other than in compliance with laws, rules and regulations applicable in the UAE or the DIFC, as the case may be, governing the issue, offering and sale of securities. This document has not been subject to review and the information contained therein has not been subject to verification by the Dubai Financial Services Authority (the "DFSA") or the Securities and Commodities Authority of the United Arab Emirates ("ESCA"). If you do not understand the contents of this document you should consult an authorised financial adviser.

In any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.

This announcement has been issued by and is the sole responsibility of NMC.

Deutsche Bank AG London Branch ("Deutsche Bank") and Numis Securities Limited ("Numis Securities"), each of which is authorised and regulated in the UK by the Financial Services Authority, SHUAA Capital psc ("SHUAA Capital") which is regulated by the UAE Central Bank, Deloitte Corporate Finance and One Financial Markets are acting exclusively for NMC and no one else in connection with the Offer and will not regard any other person as their client in relation to the Offer and will not be responsible to anyone other than NMC for providing the protections afforded to their respective clients nor for giving advice in relation to the Offer the contents of this announcement or any transaction, arrangement or other matter referred to herein. Deloitte Corporate Finance is a division of Deloitte LLP, which is authorised and regulated in the United Kingdom by the FSA in respect of regulated activities.

In connection with the Offer, Deutsche Bank, Numis Securities and SHUAA Capital or any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase Shares and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Shares and other securities of NMC or related investments in connection with the Offer or otherwise. Accordingly, references in the prospectus published in connection with the offer to the Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by, Deutsche Bank, Numis Securities and SHUAA Capital or any of their respective affiliates acting as investors for their own accounts. Deutsche Bank, Numis Securities and SHUAA Capital do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so. None of Deutsche Bank, Numis Securities and SHUAA Capital or any of their respective subsidiary undertakings, affiliates or any of their respective directors, officers, employees, advisers, agents or any other person accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or fairness of the information or opinions in this announcement (or whether any information has been omitted from the announcement) or any other information relating to NMC, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

In connection with the Offer, Deutsche Bank has been appointed to act as stabilising manager (the "Stabilising Manager"). The Stabilising Manager or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Shares or effect other transactions with a view to supporting the market price of the Shares at a higher level than that which might otherwise prevail in the open market. The Stabilising Manager is not required to enter into such transactions and such transactions may be effected on any stock market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the commencement of conditional dealings of the Shares on the London Stock Exchange and ending no later than 30 calendar days thereafter. However, there will be no obligation on the Stabilising Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilising measures, if commenced, may be discontinued at any time without prior notice. In no event will measures be taken to stabilise the market price of the Shares above the offer price. Save as required by law or regulation, neither the Stabilising Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the Offer.